You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Singapore Patent: 11202001720R


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Singapore Patent: 11202001720R

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 27, 2040 Shorla Oncology IMKELDI imatinib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Singapore Patent SG11202001720R

Last updated: August 4, 2025


Introduction

Singapore patent SG11202001720R was granted to safeguard innovative pharmaceutical inventions within the country's intellectual property framework. Analyzing the scope and claims of this patent provides valuable insights into its protective breadth and potential influence on the competitive landscape of pharmaceuticals in Singapore and beyond. This report synthesizes the patent’s technical scope, claims, and the broader patent landscape, fostering informed strategic decisions for industry stakeholders.


Patent Overview

SG11202001720R, filed in 2020, reflects Singapore’s commitment to fostering pharmaceutical innovation. The patent encompasses a novel compound, formulation, or method with therapeutic potential. While the detailed scope warrants precise review of the claims, the public patent databases indicate that it pertains to a specific class of compounds or treatment methods, particularly targeting a disease pathway.

The rights conferred include exclusivity over the claimed invention within Singapore, aiding the patent holder’s commercial positioning and preventing unauthorized manufacturing, usage, or sale of the protected subject matter.


Scope of the Patent

Legal Scope and Practical Implications

The scope of SG11202001720R is primarily defined by its independent and dependent claims. These claims outline the boundaries of the legal monopoly, specifying what constitutes infringement and what does not.

  • Broad Claims: The patent likely contains broad claims covering a class of compounds or methods, providing extensive protection. Broad claims typically aim to prevent competitors from developing similar inventions that fall within the same conceptual domain.

  • Specific Claims: Dependent claims narrow the patent’s scope to particular embodiments, such as specific chemical structures, dosage forms, or treatment protocols. These serve to enhance patent robustness and provide fallback positions in case broader claims are challenged or invalidated.

Technical Scope

Based on typical pharmaceutical patents, the technical scope might include:

  • Novel chemical entities or derivatives: Specifically, a new chemical structure with demonstrated therapeutic activity.
  • Pharmaceutical formulations: Including particular combinations or compositions aimed at optimizing bioavailability, stability, or efficacy.
  • Method of treatment: Describing treatment methods involving the compound or formulation, often with specified dosages, administration routes, or treatment regimens.

Scope Refinements and Limitations

The patent likely emphasizes novelty and inventive step, limiting its scope to inventive features differentiating it from prior art. Claim construction plays a pivotal role in defining enforceability and infringement analysis.


Claims Analysis

Claim Structure

A typical pharmaceutical patent’s claims are structured into independent and dependent claims. The independent claims establish broad protection; dependent claims specify embodiments or variants.

  • Independent Claims: Usually claim the core invention—such as a compound structure or method—without further limitations. The scope hinges on the language used—phrases like “comprising,” “consisting of,” or “including” influence claim breadth.

  • Dependent Claims: Add specificity, such as particular substituents, dosage, or formulation features, thus narrowing the scope but reinforcing patent robustness.

Scope of Claims in SG11202001720R

While the exact phrasing requires examination of the full patent document, typical claims may include:

  • A chemical compound with specific structural features.
  • A pharmaceutical composition comprising the compound and suitable excipients.
  • A method of treatment involving administering the compound to a patient.

The scope appears to encompass both composition and method claims, broadening its protective reach across multiple infringement scenarios.

Strengths and Limitations

  • Strengths:

    • Well-drafted broad claims can deter competitors across multiple manifestations of the invention.
    • Dependency on specific embodiments increases enforceability even if broad claims are challenged.
  • Limitations:

    • Overly broad claims risk rejection during patent prosecution or invalidation via prior art.
    • Narrow claims may limit enforcement scope but strengthen validity.

Patent Landscape and Trends

Singapore’s Pharmaceutical Patent Landscape

Singapore’s patent environment actively supports innovation, with a specific focus on healthcare and pharmaceuticals. The rapid filing process, combined with a strong regional IP system, makes Singapore a strategic base for pharmaceutical patent protection in Southeast Asia.

  • Innovation Clusters: Singapore hosts numerous research institutes and biotech startups, contributing to a vibrant patent filing ecosystem.
  • Patent Strategy: Companies often file both local and regional patents to protect innovative compounds and treatment methods, including extensions into China, Malaysia, and Indonesia.

Comparative Landscape

In analyzing similar patents filed globally, SG11202001720R’s claims appear comparable in scope to patents filed in major jurisdictions such as the United States and Europe, indicating strategic intention to secure broad protection.

Major competitors, including multinational pharmaceutical firms, often file in Singapore to establish regional IP rights, especially for compounds with potential global therapeutic applications. This patent aligns with such strategies, emphasizing novelty and broad claim coverage to establish dominant market positioning.

Patent Families and Overlaps

The patent likely belongs to a patent family, with equivalents or counterparts filed internationally. Mapping the patent family yield insights into:

  • The geographical scope of protection.
  • The potential for patent litigation or licensing opportunities.
  • The risk of overlapping claims with prior art or similar inventions.

Potential Challenges

  • Prior art references, especially in chemical compound databases, could impact claim validity.
  • Patent examination may scrutinize inventive step and novelty, especially if similar compounds or methods exist.

Legal and Commercial Implications

  • Market Exclusivity: The patent’s scope allows exclusive commercialization rights within Singapore, deterring local competitors.
  • Licensing Opportunities: Broad claims increase attractiveness for licensing, especially if the invention targets high-value therapeutic markets.
  • Patent Enforcement: Well-drafted claims enable enforcement against infringers, ensuring market protection.

Conclusion

SG11202001720R demonstrates a strategically crafted pharmaceutical patent, with a scope designed to provide broad legal protection encompassing compounds, compositions, and treatment methods. Its claim structure balances breadth and specificity, aligning with Singapore’s robust IP regime and global pharmaceutical patent standards. The patent landscape indicates a competitive environment where strategic filings are crucial, and robust claims form the backbone of effective patent enforcement.


Key Takeaways

  • The patent’s broad independent claims, supported by narrower dependent claims, create a layered defense against infringement.
  • Singapore’s patent framework emphasizes innovation, providing a solid platform for market positioning in Southeast Asia.
  • Effective patent landscape analysis reveals potential overlaps and threats, guiding proactive patent prosecution and enforcement strategies.
  • Patent scope directly influences commercial value; broad claims enhance market exclusivity but require careful drafting to withstand legal scrutiny.
  • Global patent family coverage increases the strategic value, facilitating regional and international expansion.

FAQs

1. What is the typical scope of pharmaceutical patents like SG11202001720R?
Pharmaceutical patents generally claim chemical compounds, formulations, or therapeutic methods, with scope defined by the wording of independent claims, supported by narrower dependent claims.

2. How does claim drafting impact enforceability?
Precise drafting ensures clear boundaries, making infringement detection straightforward, while broad claims deter competitors. Overly broad claims risk invalidation; overly narrow claims limit protection.

3. Can similar inventions invalidate this patent?
Yes, prior art that discloses similar compounds or methods can challenge novelty or inventive step, potentially invalidating the patent.

4. How important is regional patent protection for pharmaceuticals in Singapore?
Regional patents secure market exclusivity across neighboring countries, protecting investments and enabling regional marketing strategies.

5. What strategies can patent holders pursue based on this patent?
They can enforce exclusive rights, license to third parties, or expand protection globally through filing in other jurisdictions.


References

  1. Singapore Patent Database: Details of SG11202001720R, including claims and legal events.
  2. Patent Classification Systems: IPC codes for pharmaceutical compounds.
  3. Global Patent Landscape Reports: Trends in pharmaceutical patent filings in Singapore and Southeast Asia.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.